MTR and colorectal carcinoma: For MTR rs1805087, males who were homozygous for major allele (A) with the highest vitamin B2 intake had a significantly lower risk of CRC (OR, 0.57; 95% CI, 0.38 to 0.84), with a significant interaction (p for interaction= 0.02) (Supplementary Material 5).